Skip to main content
Erschienen in: Journal of Clinical Immunology 4/2012

01.08.2012

Rare Duplication or Deletion of Exons 6, 7 and 8 in CYBB Leading to X-Linked Chronic Granulomatous Disease in Two Patients from Different Families

verfasst von: Marie José Stasia, Karin van Leeuwen, Martin de Boer, Cecile Martel, Michele Mollin, Isabelle Thuret, Gerard Michel, Celine Hanson, Nancy H. Augustine, Charles Coutton, Véronique Satre, Carl T. Wittwer, Harry Hill, Dirk Roos

Erschienen in: Journal of Clinical Immunology | Ausgabe 4/2012

Einloggen, um Zugang zu erhalten

Abstract

Chronic granulomatous disease (CGD) is a rare congenital disorder in which phagocytes cannot generate superoxide (O 2 ) and other microbicidal oxidants due to mutations in one of the five components of the O 2 -generating NADPH oxidase complex. The most common form is caused by mutations in CYBB on the X chromosome, encoding gp91phox, the enzymatic subunit of the phagocyte NADPH oxidase. Here, we report two rare cases of male X-linked CGD patients, one caused by a 5.7-kb duplication of a region containing CYBB exons 6 to 8 and the other caused by a deletion of this same region. We found both the duplication in patient 1 and the deletion in patient 2 to be bordered by a GT repeat. Indeed, in control DNA, the 3′ part of CYBB intron 5 contains a GT repeat and the 5′ part of intron 8 also contains such a repeat. Duplication of exons 6, 7 and 8 in patient 1 was probably caused by a non-homologous crossing over between the two GT repeats. The deletion found in patient 2 probably arose from a similar misalignment. The results found in these patients were confirmed by multiplex ligation-dependent probe amplification. The clinical profile of XCGD is severe in both patients.
Literatur
1.
Zurück zum Zitat Segal BM, Leto TL, Gallin JI, Malech HL, Holland SM. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore). 2000;79:170–200.CrossRef Segal BM, Leto TL, Gallin JI, Malech HL, Holland SM. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore). 2000;79:170–200.CrossRef
2.
Zurück zum Zitat Van den Berg JM, van Koppen E, Ahlin A, Belohradsky BH, Bernatowska E, Corbeel L, et al. Chronic granulomatous disease: the European experience. PLoS ONE. 2009;4:e5234.PubMedCrossRef Van den Berg JM, van Koppen E, Ahlin A, Belohradsky BH, Bernatowska E, Corbeel L, et al. Chronic granulomatous disease: the European experience. PLoS ONE. 2009;4:e5234.PubMedCrossRef
3.
Zurück zum Zitat Roos D, Kuhns DB, Maddalena A, Bustamante J, Kannengiesser C, de Boer M, et al. Hematologically important mutations: the autosomal recessive forms of chronic granulomatous disease (second update). Blood Cells Mol Dis. 2010;44:291–9.PubMedCrossRef Roos D, Kuhns DB, Maddalena A, Bustamante J, Kannengiesser C, de Boer M, et al. Hematologically important mutations: the autosomal recessive forms of chronic granulomatous disease (second update). Blood Cells Mol Dis. 2010;44:291–9.PubMedCrossRef
4.
Zurück zum Zitat Roos D, Kuhns DB, Maddalena A, Roesler J, Lopez JA, Ariga T, et al. Hematologically important mutations: X-linked chronic granulomatous disease (third update). Blood Cells Mol Dis. 2010;45:246–65.PubMedCrossRef Roos D, Kuhns DB, Maddalena A, Roesler J, Lopez JA, Ariga T, et al. Hematologically important mutations: X-linked chronic granulomatous disease (third update). Blood Cells Mol Dis. 2010;45:246–65.PubMedCrossRef
5.
Zurück zum Zitat Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Scan J Clin Lab Invest. 1968;21:201–12. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Scan J Clin Lab Invest. 1968;21:201–12.
6.
Zurück zum Zitat Stasia MJ, Brion JP, Boutonnat J, Morel F. Severe clinical forms of cytochrome b negative chronic granulomatous disease (X91−) in three children with point mutation in the promoter region of the CYBB gene. J Infect Dis. 2003;188:1593–604.PubMedCrossRef Stasia MJ, Brion JP, Boutonnat J, Morel F. Severe clinical forms of cytochrome b negative chronic granulomatous disease (X91−) in three children with point mutation in the promoter region of the CYBB gene. J Infect Dis. 2003;188:1593–604.PubMedCrossRef
7.
Zurück zum Zitat Segal AW, Levi AJ. Factors influencing the entry of dye into neutrophil leucocytes in the Nitroblue Tetrazolium test. Clin Sci Mol Med. 1975;48:201–12.PubMed Segal AW, Levi AJ. Factors influencing the entry of dye into neutrophil leucocytes in the Nitroblue Tetrazolium test. Clin Sci Mol Med. 1975;48:201–12.PubMed
8.
Zurück zum Zitat Rothe G, Emmendörffer A, Oser A, Roesler J, Valet G. Flow cytometric measurement of the respiratory burst activity of phagocytes using dihydrorhodamine-1,2,3. J Immunol Methods. 1991;138:133–5.PubMedCrossRef Rothe G, Emmendörffer A, Oser A, Roesler J, Valet G. Flow cytometric measurement of the respiratory burst activity of phagocytes using dihydrorhodamine-1,2,3. J Immunol Methods. 1991;138:133–5.PubMedCrossRef
9.
Zurück zum Zitat Van Pelt LJ, van Zwieten R, Weening RS, Roos D, Verhoeven AJ, Bolscher BGJM. Limitations on the use of dihydrorhodamine-1,2,3 for flow cytometric analysis of the neutrophil respiratory burst. J Immunol Methods. 1996;191:187–96.PubMedCrossRef Van Pelt LJ, van Zwieten R, Weening RS, Roos D, Verhoeven AJ, Bolscher BGJM. Limitations on the use of dihydrorhodamine-1,2,3 for flow cytometric analysis of the neutrophil respiratory burst. J Immunol Methods. 1996;191:187–96.PubMedCrossRef
10.
Zurück zum Zitat Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680–5.PubMedCrossRef Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680–5.PubMedCrossRef
11.
Zurück zum Zitat Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some application. Proc Natl Acad Sci USA. 1979;76:4350–4.PubMedCrossRef Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some application. Proc Natl Acad Sci USA. 1979;76:4350–4.PubMedCrossRef
12.
Zurück zum Zitat Verhoeven AJ, Bolscher GJM, Meerhof L, van Zwieten R, Keijer J, Weening RS. Roos. Characterization of two monoclonal antibodies against cytochrome b 558 of human neutrophils. Blood. 1989;73:1686–94.PubMed Verhoeven AJ, Bolscher GJM, Meerhof L, van Zwieten R, Keijer J, Weening RS. Roos. Characterization of two monoclonal antibodies against cytochrome b 558 of human neutrophils. Blood. 1989;73:1686–94.PubMed
13.
Zurück zum Zitat Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156–9.PubMedCrossRef Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156–9.PubMedCrossRef
14.
Zurück zum Zitat Bolscher BGJM, de Boer M, de Klein A, Weening RS, Roos D. Point mutations in the beta-subunit of cytochrome b 558 leading to X-linked chronic granulomatous disease. Blood. 1991;77:2482–7.PubMed Bolscher BGJM, de Boer M, de Klein A, Weening RS, Roos D. Point mutations in the beta-subunit of cytochrome b 558 leading to X-linked chronic granulomatous disease. Blood. 1991;77:2482–7.PubMed
15.
Zurück zum Zitat Meischl C, de Boer M, Ahlin A, Roos D. A new exon created by intronic insertion of a rearranged LINE-1 element as the cause of chronic granulomatous disease. Eur J Hum Genet. 2000;8:697–703.PubMedCrossRef Meischl C, de Boer M, Ahlin A, Roos D. A new exon created by intronic insertion of a rearranged LINE-1 element as the cause of chronic granulomatous disease. Eur J Hum Genet. 2000;8:697–703.PubMedCrossRef
16.
Zurück zum Zitat Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res. 2002;30:e57.PubMedCrossRef Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res. 2002;30:e57.PubMedCrossRef
17.
Zurück zum Zitat Wouters D, van Schouwenburg P, van der Horst A, de Boer M, Schooneman D, Kuijpers TW, et al. High-throughput analysis of the C4 polymorphism by a combination of MLPA and isotype-specific ELISA's. Mol Immunol. 2009;46:592–600.PubMedCrossRef Wouters D, van Schouwenburg P, van der Horst A, de Boer M, Schooneman D, Kuijpers TW, et al. High-throughput analysis of the C4 polymorphism by a combination of MLPA and isotype-specific ELISA's. Mol Immunol. 2009;46:592–600.PubMedCrossRef
18.
Zurück zum Zitat Menten B, Maas N, Thienpont B, Buysse K, Vandesompele J, Melotte C, et al. Emerging patterns of cryptic chromosomal imbalance in patients with idiopathic mental retardation and multiple congenital anomalies: a new series of 140 patients and review of published reports. J Med Genet. 2006;43:625–33.PubMedCrossRef Menten B, Maas N, Thienpont B, Buysse K, Vandesompele J, Melotte C, et al. Emerging patterns of cryptic chromosomal imbalance in patients with idiopathic mental retardation and multiple congenital anomalies: a new series of 140 patients and review of published reports. J Med Genet. 2006;43:625–33.PubMedCrossRef
19.
Zurück zum Zitat Dinauer MC, Pierce EA, Erickson RW, Muhlebach TJ, Messner H, Orkin SH, et al. Point mutation in the cytoplasmic domain of the neutrophil p22-phox cytochrome b subunit is associated with a nonfunctional NADPH oxidase and chronic granulomatous disease. Proc Natl Acad Sci USA. 1991;88:11231–5.PubMedCrossRef Dinauer MC, Pierce EA, Erickson RW, Muhlebach TJ, Messner H, Orkin SH, et al. Point mutation in the cytoplasmic domain of the neutrophil p22-phox cytochrome b subunit is associated with a nonfunctional NADPH oxidase and chronic granulomatous disease. Proc Natl Acad Sci USA. 1991;88:11231–5.PubMedCrossRef
20.
Zurück zum Zitat Hill HR, Augustine NH, Pryor RJ, Reed GH, Bagnato JD, Tebo AE, et al. Rapid genetic analysis of X-linked chronic granulomatous disease by high-resolution melting. J Mol Diagn. 2010;12:368–76.PubMedCrossRef Hill HR, Augustine NH, Pryor RJ, Reed GH, Bagnato JD, Tebo AE, et al. Rapid genetic analysis of X-linked chronic granulomatous disease by high-resolution melting. J Mol Diagn. 2010;12:368–76.PubMedCrossRef
21.
Zurück zum Zitat Rabbani H, de Boer M, Ahlin A, Sundin U, Elinder G, Hammarström L, et al. A 40-base pair duplication in the gp91phox gene leading to X-linked chronic granulomatous disease. Eur J Haematol. 1993;51:218–22.PubMedCrossRef Rabbani H, de Boer M, Ahlin A, Sundin U, Elinder G, Hammarström L, et al. A 40-base pair duplication in the gp91phox gene leading to X-linked chronic granulomatous disease. Eur J Haematol. 1993;51:218–22.PubMedCrossRef
22.
Zurück zum Zitat Gentsch M, Kaczmarczyk A, van Leeuwen K, de Boer M, Kaus-Drobek M, Dagher MC, et al. Alu-repeat-induced deletions within the NCF2 gene causing p67-phox-deficient chronic granulomatous disease (CGD). Hum Mutat. 2010;31:151–8.PubMedCrossRef Gentsch M, Kaczmarczyk A, van Leeuwen K, de Boer M, Kaus-Drobek M, Dagher MC, et al. Alu-repeat-induced deletions within the NCF2 gene causing p67-phox-deficient chronic granulomatous disease (CGD). Hum Mutat. 2010;31:151–8.PubMedCrossRef
Metadaten
Titel
Rare Duplication or Deletion of Exons 6, 7 and 8 in CYBB Leading to X-Linked Chronic Granulomatous Disease in Two Patients from Different Families
verfasst von
Marie José Stasia
Karin van Leeuwen
Martin de Boer
Cecile Martel
Michele Mollin
Isabelle Thuret
Gerard Michel
Celine Hanson
Nancy H. Augustine
Charles Coutton
Véronique Satre
Carl T. Wittwer
Harry Hill
Dirk Roos
Publikationsdatum
01.08.2012
Verlag
Springer US
Erschienen in
Journal of Clinical Immunology / Ausgabe 4/2012
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-012-9667-2

Weitere Artikel der Ausgabe 4/2012

Journal of Clinical Immunology 4/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Bei Herzinsuffizienz muss „Eisenmangel“ neu definiert werden!

16.05.2024 Herzinsuffizienz Nachrichten

Bei chronischer Herzinsuffizienz macht es einem internationalen Expertenteam zufolge wenig Sinn, die Diagnose „Eisenmangel“ am Serumferritin festzumachen. Das Team schlägt vor, sich lieber an die Transferrinsättigung zu halten.

Herzinfarkt mit 85 – trotzdem noch intensive Lipidsenkung?

16.05.2024 Hypercholesterinämie Nachrichten

Profitieren nach einem akuten Myokardinfarkt auch Betroffene über 80 Jahre noch von einer intensiven Lipidsenkung zur Sekundärprävention? Um diese Frage zu beantworten, wurden jetzt Registerdaten aus Frankreich ausgewertet.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.